We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.9B
AUM Growth
+$373M
Cap. Flow
+$123M
Cap. Flow %
0.82%
Top 10 Hldgs %
56.71%
Holding
1,166
New
198
Increased
342
Reduced
449
Closed
173

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$32M
2
AVGO icon
Broadcom
AVGO
+$31.6M
3
VZ icon
Verizon
VZ
+$27.3M
4
CCJ icon
Cameco
CCJ
+$26.1M
5
MPLX icon
MPLX
MPLX
+$23.1M

Sector Composition

Rank Sector Weight
1 Energy 66.42%
2 Technology 4.66%
3 Financials 3.55%
4 Consumer Discretionary 3.47%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGE icon
351
Apogee Therapeutics
APGE
$10.2B
$2.08M 0.01%
35,485
+418
+1% +$20K
TCOM icon
352
Trip.com Group
TCOM
$28.1B
$2.08M 0.01%
35,070
+5,273
+18% +$244K
GERN icon
353
Geron
GERN
$956M
$2.07M 0.01%
455,654
-7,017
-2% -$31.9K
KFRC icon
354
Kforce
KFRC
$1.02B
$2.07M 0.01%
33,653
+14,394
+75% +$921K
IDYA icon
355
IDEAYA Biosciences
IDYA
$3.48B
$2.06M 0.01%
64,890
+5,838
+10% +$221K
VRSK icon
356
Verisk Analytics
VRSK
$27.1B
$2.05M 0.01%
7,648
+3,559
+87% +$963K
ARRY icon
357
Array Technologies
ARRY
$834M
$2.04M 0.01%
309,377
-24,985
-7% -$205K
DUOL icon
358
Duolingo
DUOL
$5.91B
$2.04M 0.01%
7,240
-1,272
-15% -$261K
CGON icon
359
CG Oncology
CGON
$6.3B
$2.03M 0.01%
53,859
+1,878
+4% +$65.8K
SHLS icon
360
Shoals Technologies Group
SHLS
$1.52B
$2.02M 0.01%
360,309
-57,223
-14% -$342K
OGE icon
361
OGE Energy
OGE
$10.3B
$2M 0.01%
48,836
-1,821
-4% -$70.7K
ELV icon
362
Elevance Health
ELV
$81.6B
$1.98M 0.01%
3,815
-4,257
-53% -$2.27M
VERA icon
363
Vera Therapeutics
VERA
$2.57B
$1.96M 0.01%
44,266
+1,432
+3% +$54.3K
ACAD icon
364
Acadia Pharmaceuticals
ACAD
$4.32B
$1.95M 0.01%
127,096
-1,770
-1% -$29.5K
AGIO icon
365
Agios Pharmaceuticals
AGIO
$2.22B
$1.91M 0.01%
43,006
-1,286
-3% -$58.4K
FISV
366
Fiserv Inc
FISV
$27.8B
$1.91M 0.01%
10,605
-2,362
-18% -$390K
TTD icon
367
Trade Desk
TTD
$8.38B
$1.9M 0.01%
17,364
-672
-4% -$67K
SQM icon
368
Sociedad Química y Minera de Chile
SQM
$19.4B
$1.89M 0.01%
45,357
+12,253
+37% +$469K
PTC icon
369
PTC
PTC
$14.2B
$1.87M 0.01%
10,349
+211
+2% +$37.1K
AMSC icon
370
American Superconductor
AMSC
$1.45B
$1.85M 0.01%
78,579
-3,206
-4% -$73.9K
UGI icon
371
UGI
UGI
$7.99B
$1.85M 0.01%
+73,930
New +$1.78M
EWTX icon
372
Edgewise Therapeutics
EWTX
$4.42B
$1.84M 0.01%
68,906
-3,937
-5% -$78.3K
TMO icon
373
Thermo Fisher Scientific
TMO
$210B
$1.83M 0.01%
2,957
+1,744
+144% +$1.03M
NET icon
374
Cloudflare
NET
$92.6B
$1.83M 0.01%
22,605
-1,410
-6% -$113K
GPRE icon
375
Green Plains
GPRE
$1.15B
$1.81M 0.01%
133,854
-10,985
-8% -$161K

Similar funds

ALPS Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, ALPS Advisors held 1,166 positions worth $14.9B, up 2.6% from $14.6B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

ALPS Advisors's Q3 2024 filing shows 198 new, 342 increased, 449 reduced and 173 closed positions. Its largest new stake was LyondellBasell Industries: 258,651 shares worth $24.8M. The largest sale was JPMorgan Chase, an estimated $32M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 69% a quarter earlier, followed by Technology and Financials.

  • ALPS Advisors's largest Q3 2024 buy was LyondellBasell Industries: 258,651 shares worth $24.8M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2024, an estimated $48.3M increase.
  • ALPS Advisors's biggest Q3 2024 reduction was JPMorgan Chase, cutting an estimated $32M.
  • ALPS Advisors fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $14.5M.
  • ALPS Advisors's ten largest holdings make up 57% of its $14.9B portfolio in Q3 2024.
  • ALPS Advisors opened 198 new positions and closed 173 in Q3 2024.
  • ALPS Advisors's portfolio value rose 2.6% quarter-over-quarter to $14.9B.

Based on ALPS Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.